Therma Bright IncOTCQB:TBRIFView on Canadian Exchange
- LAST PRICE0.0188
- TODAY'S CHANGE (%)-0.0002 (-0.7916%)
- Bid / Lots0.0176/ 110
- Ask / Lots0.0200/ 100
- Open / Previous Close0.0185 / 0.0190
- Day Range
- 52 Week Range
- Volume30,153
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TBRIF |
|---|---|---|
| 09:32 ET | 453 | 0.0185 |
| 11:34 ET | 2000 | 0.0187 |
| 02:05 ET | 25000 | 0.01875 |
| 03:19 ET | 2700 | 0.0188 |
Nov 18, 2024
Therma Bright to Spin Off Consumer Product Portfolio to Create Two Publicly Traded Companies, from 6:01AM ET on Monday Nov 18, 2024 by Dow Jones
6:01AM ET on Monday Nov 18, 2024 by Dow Jones
Nov 11, 2024
Therma Bright Announces Shares for Debt Issuance, from 5:02PM ET on Monday Nov 11, 2024 by Dow Jones
5:02PM ET on Monday Nov 11, 2024 by Dow Jones
Oct 28, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Therma Bright Inc | 10.5M | --- | --- |
Company Information
Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.
Contact Information
- Headquarters
- 345 Danforth AvenueTORONTO, ON, Canada M4K 1N7
- Phone
- 416-867-2353
- Fax
- 416-867-4566
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $10.5M |
|---|---|
Revenue (TTM) | $25.9K |
Shares Outstanding | 420.6M |
Therma Bright Inc does not pay a dividend. | |
Beta | 2.82 |
EPS | $-0.01 |
Book Value | $0.00 |
P/E Ratio | --- |
Price/Sales (TTM) | 406.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -9,906.50% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
